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predictive factors for bacteremia 
in febrile infants with urinary tract 
infection
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this study aimed to investigate the predictive factors of concomitant bacteremia occurring in febrile 
infants who initially presented with pyuria and fever, and were subsequently diagnosed with culture-
proven urinary tract infection (UTI). We conducted a retrospective cohort study for January 2010–
October 2018 that included infants younger than six months with febrile UTI at a tertiary hospital. 
The study included 463 patients, of whom 34 had a concomitant bacteremic UTI. Compared to those 
in the non-bacteremic urinary tract infection (Uti) group, the bacteremic Uti group had a lower mean 
age; higher levels of C-reactive protein (CRP), delta neutrophil index (DNI, reflects the fraction of 
immature granulocytes) and blood urea nitrogen (BUn); lower levels of hemoglobin (Hb) and albumin; 
and a lower platelet count. Vesicoureteral reflux (VUR) was detected nearly twice as often in patients 
with bacteremic UTI compared to those with non-bacteremic UTI (59.3% vs. 30.6%; P = 0.003). 
Univariate logistic analyses showed that age ≤90 days; higher DNI, CRP, and creatinine levels; lower 
Hb and albumin levels; and the presence of VUR were predictors for bacteremic Uti. on multivariate 
logistic regression analysis, age ≤90 days, higher DNI and CRP levels, and the presence of VUR were 
independent predictors of bacteremic Uti. the area under the receiver operating characteristic curve of 
the multivariate model was 0.859 (95% CI, 0.779–0.939; P < 0.001). Age ≤90 days, higher DNI and CRP 
values may help predict bacteremia of febrile infants younger than 6 months with UTI. Vesicoureteral 
reflux imaging is also recommended in infants with bacteremic UTI to evaluate VUR.
Urinary tract infection (UTI) has been described as the most common serious bacterial infection in febrile 
infants1. The rate of concomitant bacteremia in febrile UTI varies from 5% to 31%, depending on various loca-
tions and patient cohorts2,3. Although a recent study has shown that outcomes were good among infants with 
bacteremic UTI4, infants with concomitant bacteremic UTI are still prone to adverse outcomes such as pro-
longed admission, shock, bacterial meningitis, and intensive-care unit admission5. Early diagnosis and prompt 
decision-making on the initial treatment of young febrile infants suspected of having bacteremia are important 
but not feasible because confirming positive blood cultures is usually time-consuming.
Several factors have been previously reported to predict bacteremic UTI in pediatric patients: younger age3,6; 
clinical presentation such as ill appearance5,7 and feeding problems8; laboratory parameters including increased 
creatinine levels9,10; high levels of inflammatory markers such as white blood cell (WBC) count5, presence of 
bands5 and C-reactive protein (CRP)7,10,11; and genitourinary (GU) tract malformations8.
However, the clinical signs or symptoms of UTI are usually vague and unspecific in young infants12. Clinically 
determining whether children have serious complications when they may not appear ill is difficult for physi-
cians13. Pantell et al. reported that among 3,066 febrile infants aged ≤3 months, only 58.1% of the infants with 
bacteremia or bacterial meningitis appeared ill14. In addition, Roman et al. reported no major clinical differences 
between infants with bacteremic and non-bacteremic UTI at presentation4. Therefore, objective predictors will be 
more useful to identify concomitant bacteremia at the initial presentation. Still, the predictive value of inflamma-
tory markers such as WBC, total band count, CRP, and serum creatinine level remains controversial because of 
discordant results4,6,9,15,16. Furthermore, GU abnormality showed no statistical significance in terms of predicting 
concomitant bacteremia/sepsis in recent studies9,10.
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Preceding pediatric studies have reported that the prevalence of concomitant bacteremic UTI was mostly lim-
ited to infants younger than six months4,6. The prevalence of UTI in infants aged 3–6 months was similar to that in 
those younger than three months in a previous meta-analysis17; nonetheless, studies that assessed the risk factors 
in predicting bacteremic UTI were mainly focused on infants younger than three months5,7,10,11.
This study aimed to investigate the initial risk factors for bacteremia in infants aged younger than six months 
with febrile UTI at presentation, confirming previously established parameters and identifying other new labo-
ratory findings.
Methods
This retrospective cohort study was performed in one tertiary referral hospital from January 2010 to October 
2018. The researchers reviewed the medical data of infants ≤ 6 months initially presenting with fever (≥38.0 °C) 
and pyuria and eventually diagnosed as having culture-proven UTI after admission. Pyuria was defined by urine 
WBC count >5 cells/high power field (HPF)18. UTI was defined on the basis of the urine culture results: from 
a catheter urine specimen culture with a colony count ≥50,000 or from a bag-collected specimen culture with 
≥100,000 colonies4,18. Cases were excluded when two or more organisms were isolated on culture.
Data on patient age and sex, route of admission, duration of fever and hospitalization, bacterium isolated from 
urine and blood cultures, initial laboratory findings, the presence of vesicoureteral reflux (VUR; confirmed by 
voiding cystourethrography [VCUG]/radionuclide cystoscopy/video urodynamic studies19), and 99mtechnetium 
dimercaptosuccinic acid (DMSA) renal scan results during the acute stage (within seven days from admission) 
were collected from the medical records. DMSA renal scan findings were classified according to the previous 
study20.
At the participating hospital, blood and urine cultures are routinely performed for febrile patients admitted 
with UTI. At least two sets of blood cultures were drawn before antibiotic therapy. Concomitant bacteremic UTI 
is defined when the same bacterium is isolated from both urine and blood cultures in the same patient within 
48 h9. Only patients for whom both urine culture and blood culture were performed were included in this study.
Follow-up data including urinalysis at six months and one year after admission, and DMSA renal scan six 
months after admission21 were obtained. Estimated glomerular filtration rate (eGFR) is currently the most 
common way of assessing the degree of kidney impairment and following the course of a disease22. However, 
eGFR is not routinely examined for febrile patients admitted with UTI at our institution. Therefore, we have 
retrospectively reviewed the medical records of enrolled patients; if the results of eGFR were present after index 
UTI, we obtained the last result for eGFR and its date of testing to calculate the follow-up time from the index 
UTI admission. We calculated the cystatin C-based eGFR using the Chronic Kidney Disease in Children study 
(CKiD)-derived equation23. An eGFR ≥ 90 mL/min/1.73 m2 was regarded as normal24,25.
Statistical analyses. Patients with bacteremic UTI were compared to those with non-bacteremic UTI. 
Demographics, clinical, and laboratory data were presented as mean ± standard deviation or frequency. 
Categorical variables were compared using the chi-squared test. Continuous variables were compared using the 
Student t-test or Mann–Whitney test, as appropriate. Univariate and multivariate binary logistic regression anal-
yses were performed to identify the significant risk factors for bacteremic UTI, and the odds ratio (OR) and 
95% confidence interval (CI) were calculated. If variables were found to be significant in the univariate analyses 
(P < 0.05), they were included in the multivariate regression analysis.
Receiver operating characteristic (ROC) curves were analyzed by estimating the area under the curve (AUC) 
to examine the predicting capacity of laboratory parameters and multivariate model in bacteremic UTI. The opti-
mal cutoff values were calculated on the basis of the Youden index. Statistical analyses were performed using SPSS 
version 23.0 for Windows (SPSS Inc., Chicago, IL, USA) and MedCalc Statistical Software version 18.6 (MedCalc 
Software, Ostend, Belgium). P < 0.05 was considered significant.
ethical approval. This study was approved by the Institutional Review Board at Yonsei University Health 
System (approval number: 4-2018-1086). All research was performed in accordance with relevant guidelines and 
regulations. The requirement for written informed consents was waived by the Institutional Review Board due to 
retrospective study design.
Results
Baseline characteristics. During the study period, 463 cases of UTI that fully met inclusion criteria were 
enrolled. Among them, 34 were determined to be bacteremic UTI. The mean age was 3.6 ± 1.4 months, and 344 
(74.3%) were boys, and 182 (39.3%) were younger than 90 days (Table 1).
Clinical and laboratory differences between bacteremic and non-bacteremic UTI. The mean 
age of the bacteremic UTI group (2.8 ± 1.5 months; range, 1.2–5.7 months) was younger than that of the 
non-bacteremic UTI group (3.6 ± 1.4 months; range, 1.0–6.0 months) (P < 0.001). The bacteremic UTI group 
exhibited shorter fever duration before admission (P = 0.032); higher CRP level (P < 0.001), delta neutrophil 
index (DNI), which reflects the level of immature granulocytes (P = 0.006), and blood urea nitrogen (BUN) 
(P < 0.001); and lower levels of hemoglobin (Hb)(P = 0.021), albumin (P = 0.002), and platelet counts (P = 0.043); 
No significant differences were found in sex, total duration of fever, WBC, absolute neutrophil count, erythrocyte 
sedimentation rate, sodium, creatinine, aspartate aminotransferase (AST), alanine aminotransferase (ALT), total 
bilirubin, or presence of a positive urine nitrite test (Table 1). Escherichia coli was the most commonly isolated 
organism in both bacteremic and non-bacteremic UTI (82.4% and 87.6%, respectively) (Table 2).
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Prevalence of vesicoureteral reflux. Among all enrolled patients, confirmative imaging studies for VUR 
were performed on 259 patients (55.9%). The prevalence of VUR was significantly higher in the bacteremic UTI 
group compared to the non-bacteremic UTI group (59.3% vs. 30.6%; P = 0.003).
Variables
Bacteremic 
UTI (n = 34)
Non-bacteremic 
UTI (n = 429) P-value
Admission route 0.37a
ED 29 (85.3%) 338 (78.8%)
OPD 5 (14.7%) 91 (21.2%)
Urine samples 0.745a
Catheterization 4 (11.8) 59 (13.8)
Urine bag 30 (88.2) 370 (86.2)
Age (month) 2.8 ± 1.5 3.6 ± 1.4 <0.001b
Age ≤ 90 days 24 (70.6%) 158 (36.8%) <0.001a
Male sex (%) 22 (64.7%) 322 (75.1%) 0.184a
Length of stay (days) 7.4 ± 3.9 4.8 ± 1.7 0.001c
Duration of fever (days)
Total duration 2.8 ± 1.5 2.6 ± 1.6 0.573b
Before admission 1.6 ± 0.9 2.1 ± 1.3 0.032b
WBC (/μL) 13.9 ± 7.7 15.4 ± 5.4 0.268c
ANC (/μL) 8.3 ± 5.3 8.4 ± 4 0.840b
Hb (g/dL) 10.5 ± 0.8 10.9 ± 1 0.021b
Platelet count (k/μL) 411 ± 151 458 ± 127.7 0.043b
CRP (mg/L) 66.3 ± 42.9 42.4 ± 33.7 <0.001b
DNI (%) 4.1 ± 6.3 0.9 ± 2.1 0.006c
ESR (mm/H) 39.6 ± 26.5 36.6 ± 26.8 0.549b
Na (mmol/L) 136.7 ± 4.2 137.4 ± 2.2 0.084b
AST (IU/L) 31.6 ± 14.6 36.3 ± 35.4 0.444b
ALT (IU/L) 27.5 ± 21.6 29.4 ± 34.2 0.756b
Albumin (g/dL) 3.8 ± 0.3 3.9 ± 0.3 0.002b
Total bilirubin (mg/dL) 0.8 ± 0.7 0.6 ± 0.7 0.169b
BUN (mg/dL) 11.4 ± 5.7 8.2 ± 4.8 <0.001b
Cr (mg/dL) 0.3 ± 0.2 0.2 ± 0.1 0.125c
Urine nitrite test (+) 22 (64.7%) 226 (52.7%) 0.176a
Table 1. Comparison between infants with bacteremia and non-bacteremia with febrile urinary tract infection 
at admission. Data are presented as case numbers, percentages, or the mean ± standard deviation. Statistically 
significant differences were demonstrated using aChi-square test, bStudent t-test, and cMann–Whitney test. 
ANC, absolute neutrophil count; AST, aspartate aminotransferase; ALT, alanine aminotransferase; BUN, 
blood urea nitrogen; Cr, Creatinine; CRP, C-reactive protein; ED, emergency department; ESR, erythrocyte 
sedimentation rate; Hb, hemoglobin; Na, sodium; OPD, outpatient department; UTI, urinary tract infection; 
WBC, white blood cell.
Bacterial isolates
Bacteremic UTI 
(n = 34)
Non-bacteremic 
UTI (n = 429)
Citrobacter freundii 0 (0.0%) 4 (0.9%)
Citrobacter koseri 0 (0.0%) 1 (0.2%)
Enterobacter aerogenes 3 (8.8%) 14 (3.3%)
Enterobacter cloacae 2 (5.9%) 4 (0.9%)
Enterococcus faecalis 0 (0.0%) 2 (0.5%)
Enterococcus faecium 1 (2.9%) 0 (0.0%)
Escherichia coli 28 (82.4%) 376 (87.6%)
Klebsiella pneumoniae 0 (0.0%) 21 (4.9%)
Klebsiella oxytoca 0 (0.0%) 2 (0.5%)
Klebsiella ozaenae 0 (0.0%) 1 (0.2%)
Proteus mirabilis 0 (0.0%) 1 (0.2%)
Pseudomonas aeruginosa 0 (0.0%) 2 (0.5%)
Raoultella planticola 0 (0.0%) 1 (0.2%)
Table 2. Bacterial strains isolated from blood and urine cultures. Data are presented as number (percent).
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Risk factor analysis for bacteremic Uti. Univariate logistic regression analyses showed that age ≤90 
days; higher DNI, CRP, and creatinine levels; lower Hb and albumin levels; and the presence of VUR were sig-
nificantly associated with increased risks of bacteremic UTI (Table 3). The multivariate model was based on 257 
patients after removing missing values [n = 206; the missing values were from CRP (n = 3) and the confirmative 
imaging study of VUR (n = 204). One patient was had neither CRP nor imaging study of VUR]. On the basis of 
multivariate logistic regression analysis, age ≤90 days (odds ratio [OR]: 10.67, 95% CI: 2.90–39.20, P < 0.001); 
higher DNI (OR: 1.25, 95% CI: 1.08–1.44, P = 0.002), and CRP (OR: 1.02, 95% CI: 1.01–1.04, P < 0.001); and 
presence of VUR (OR: 3.66, 95% CI: 1.33–10.05, P = 0.012) were independent predictors of bacteremic UTI 
(Table 3). ROC analysis of our multivariate model revealed the diagnostic performance of bacteremic UTI was 
0.859 (95% CI, 0.779–0.939; P < 0.001) (Fig. 1).
Cutoff values of laboratory tests for predicting bacteremic UTI. The ROC analysis revealed that 
optimal cutoff values for predicting bacteremic UTI of CRP and DNI alone were DNI alone >1.2% (AUC, 
0.727; 95% CI, 0.684–0.768; P < 0.001; sensitivity, 61.8%; specificity, 77.9%; negative predictive value [NPV], 
96.3%; positive predictive value [PPV], 18.1%) and CRP alone >45.1 mg/L (AUC, 0.680; 95% CI, 0.635–0.723; 
P < 0.001; sensitivity, 70.6%; specificity, 62.0%; NPV; 96.4% PPV, 12.9%), respectively (Supplementary Table S1 
and Supplementary Fig. S1).
Univariate Multivariate
Variables OR 95% CI P-value OR 95% CI P-value
Albumin (g/dL) 0.15 0.05–0.51 0.002 0.71 0.07–6.85 0.768
CRP (mg/L) 1.02 1.01–1.02 <0.001 1.02 1.01–1.04 <0.001
Cr (mg/dL) 13.57 1.31–141.13 0.029 19.38 0.68–552.59 0.083
DNI (%) 1.24 1.13–1.36 <0.001 1.25 1.08–1.44 0.002
Hb (g/dL) 0.66 0.46–0.94 0.022 1.67 0.88–3.15 0.116
Age
≤ 90 days 4.12 1.92–8.83 <0.001 10.67 2.90–39.20 <0.001
> 90 days reference
VUR
(+) 3.30 1.46–7.47 0.004 3.66 1.33–10.05 0.012
(–) reference
Table 3. Risk factors for bacteremic urinary tract infection in febrile infants with pyuria. CI, confidence 
interval; CRP, C-reactive protein; Cr, creatinine; DNI, delta neutrophil index; Hb, hemoglobin; OR, odds ratio; 
VUR, vesicoureteral reflux. Odds ratio, 95% confidence intervals and P-values were calculated by binary logistic 
regression analysis.
Figure 1. Receiver operating characteristic (ROC) curves for the multivariate model in discriminating bacteremic 
urinary tract infection from non-bacteremic urinary tract infection. The area under the ROC curve is 0.859.
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findings of DMSA renal scan. The results of DMSA scan during the acute stage (within seven days 
after admission) were obtained in 387(83.6%) patients [bacteremic UTI patients = 23 (67.6%, 23/34) vs. 
non-bacteremic UTI patients = 364 (84.8%, 364/429)]. Cortical defects were more frequently found in bac-
teremic UTI patients (60.9%) than non-bacteremic UTI patients (33.0%) during the acute stage (P = 0.033) 
(Supplementary Table S2).
However, the majority of enrolled patients were lost to follow-up; therefore, the results of the DMSA scan at 
six months after admission were only obtained for 23 patients [bacteremic UTI patients = 2 vs. non-bacteremic 
UTI patients = 21]. Most patients (91.3%, 21/23) showed resolution or improved status of cortical defects on 
follow-up DMSA scan (Supplementary Table S2). One patient who was initially diagnosed as a non-bacteremic 
UTI showed a renal scar on the follow-up DMSA scan.
proteinuria at follow up. The lack of long-term follow-up data for enrolled patients means that we could 
only obtain follow-up urinalysis at six-months [bacteremic UTI patients = 11 (32.4%, 11/34) vs. non-bacteremic 
UTI patients = 109 (25.4%, 109/429)] and one-year [bacteremic UTI patients = 14 (41.2%, 14/34) vs. 
non-bacteremic UTI patients = 33 (7.7%, 33/429)] after admission on follow-up visit (± 30 days). There was 
no significant difference in positive proteinuria cases in bacteremic vs. non-bacteremic UTI patients on the 
follow-up urinalysis (Supplementary Table S3).
Renal function at follow up. eGFR was obtained from 53 patients (11.4%) [Bacteremic UTI = 9 (26.5%, 
9/34) vs. Non-bacteremic UTI = 44 (10.3%, 44/429) until Jan 2020. The serum cystatin C concentration, eGFR, 
and number of cases with eGFR <90 mL/min/1.73 m2 showed no significant differences between bacteremic UTI 
and non-bacteremic UTI patients (Supplementary Table S4).
Discussion
This study showed that age ≤90 days, higher levels of CRP and DNI, and the presence of VUR were significantly 
associated with concomitant bacteremic UTI in multivariate analysis. Our results also suggest that children with 
bacteremic UTI should be examined by VCUG or radionuclide cystourethrography because of the high preva-
lence (59.3%) of VUR.
Concomitant bacteremia or sepsis in UTI is associated with a longer length of hospital stay and higher mor-
bidity and mortality rates in both adults or children5,15; thus, various studies have been conducted to identify early 
factors for predicting concomitant bacteremia.
One of the best known risk factors for concomitant bacteremic UTI is age. In pediatric studies, the rate of 
concomitant bacteremic UTI decreased with age2–4,6,10. Honkinen et al. reported that among patients <16 years 
of age with bacteremic UTI, 66% were aged 1 week to 3 months, 22% were aged 3–11 months, and 12% were aged 
≥12 months8. Roman et al.4 reported an inverse relationship between the risk of bacteremic UTI and age, with a 
very low risk after 6 months. In accordance with previous studies, our results revealed higher numbers of infants 
aged ≤90 days in the bacteremic UTI group compared to in the non-bacteremic UTI group (70.6% vs. 36.8%). 
This tendency can be explained by the immature immune systems and more frequent hematogenous spread of 
infection in children of younger ages12.
In contrast, in adult patients, the rate of concomitant bacteremia with UTI is associated with old age15,26,27. Van 
Nieuwkoop et al. reported in a multicenter trial that bacteremia likely occurs 2.4 times in febrile patients with 
UTI > 65 years27. Elderly individuals are predisposed to sepsis because of their comorbidities, lengthy hospitali-
zations, reduced immunity, and functional limitations related to aging28.
Several studies have reported an association between sex and bacteremic UTI, males during the neonatal 
period10 and older ages26. However, beyond the neonatal period, many studies showed that sex did not increase 
the risk of bacteremic UTI4,7,9,16.
Patients with bacteremia had shorter fever duration prior to admission. Bacteremic UTI patients might pres-
ent earlier than non-bacteremic UTI patients because of their poor general condition or non-bacteremic UTI 
patients might present to the hospital later in the disease’s course where the bacteremia have already disappeared. 
Unfortunately, we could not investigate what factors might influence bacteremia (e.g. the use of oral antibiotics 
prior to admission or hospital accessibility). Explaining this finding will require further future studies.
Well-known inflammatory markers, such as CRP and procalcitonin (PCT), have been studied to predict 
bacteremia because they can be rapidly evaluated compared to confirming positive blood cultures, which is 
time-consuming. Higher CRP levels have been frequently observed in pediatric patients with bacteremic UTI7,8,16, 
but there are no established optimal cutoff values for CRP. Kim et al.16 reported that an elevated CRP level 
(>0.5 mg/dL) independently increased the risk of bacteremic UTI (adjusted OR, 8.13). Velasco-Zuniga et al.7 
studied 140 febrile infants aged 30–90 days with a positive urine culture and showed that CRP > 40 mg/L highly 
predicted adverse events (bacteremia or meningitis). These findings are similar to those of the present study, for 
which the optimal cutoff value of CRP alone was >45.1 mg/L for predicting bacteremic UTI.
PCT is a valid marker for diagnosing bacterial infections. Hernandez-Bou et al.12 studied afebrile infants aged 
29–90 days with UTI and reported that the PCT level was significantly higher in infants with bacteremic UTI than 
in infants with non-bacteremic UTI (P = 0.031). The cutoff PCT of ≥0.7 ng/mL showed a sensitivity, specificity, 
PPV, and NPV of 87.5%, 71.1%, 8.3%, and 99.5%, respectively, as a predictor of bacteremia. In a prospective 
multicenter study involving 581 adults with UTI (median age, 66 years), van Nieuwkoop27 reported that a PCT 
cutoff value >0.25 μg/L was highly predictive of concomitant bacteremic UTI (sensitivity, 95%; specificity, 50%; 
PPV, 36%; NPV, 97%). The diagnostic accuracy of PCT for predicting bacteremia was 0.73 (95% CI: 0.68–0.77)27 
to 0.82 (95% CI: 0.77–0.86)12 in the above studies. ROC analysis of our multivariate model revealed that the 
accuracy was 0.859 (95% CI, 0.779–0.939), which is higher than that of studies that only used PCT as a predictive 
factor. Unfortunately, we did not investigate the association between PCT levels and the presence of bacteremic 
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UTI, and thus further studies are needed to confirm the predictive value of PCT in febrile infants for diagnosing 
concomitant bacteremic UTI at presentation.
DNI is a fraction of immature granulocytes previously reported as a useful marker for diagnosing bacteremia/
sepsis with a higher overall diagnostic accuracy than that of traditional markers, such as PCT and CRP29. DNI 
can be determined by performing a complete blood count using an automated blood cell analyzer, and thus is 
rapid and inexpensive method for estimating bacteremia. In this study, DNI alone showed a moderate diagnostic 
capacity for detection of bacteremia (AUC, 0.727), with an optimal cutoff value of 1.2%. This is the first study to 
investigate the value of DNI for predicting bacteremia in infants with UTI. Ahn et al. reported that the best cutoff 
value of DNI for immunocompetent children (median age, 2.6 years) in predicting bacteremia, regardless of eti-
ology, was 4.4%, with sensitivity and specificity values of 44.4% and 94.7%, respectively30. Additional studies are 
needed to determine age-appropriate, reliable cutoff values of DNI under various clinical conditions.
Albumin is also a potent prognostic marker of sepsis. A low albumin level has been also found in patients with 
concomitant bacteremic UTI26,31. In studies involving adults, Leibovici et al.31 identified a low serum albumin 
level as an independent predictor of bacteremia in hospitalized patients with UTI. Bahagon et al.26 also found 
that the serum albumin level was significantly low in patients with bacteremic UTI compared to in those with 
non-bacteremic UTI, but found no association in multivariate analysis. We observed that a lower albumin level 
increased the risk of bacteremic UTI in univariate analysis (unadjusted OR, 0.15), but not in the multivariate 
analysis.
A higher creatinine level was associated with bacteremic UTI in univariate regression analysis in our study, 
supporting previous findings9,10. However, a relationship in the multivariate model was not observed, similar to 
in a previous study8. In an adult study, Leibovici et al.31 identified high creatinine levels as an independent risk 
factor for bacteremic UTI in hospitalized patients. Megged9 retrospectively reviewed 464 culture-proven pediatric 
patients with UTI who were admitted to the emergency department (mean age, 52 ± 48 months) and found that 
among clinical variables (urine collection methods, age <3 months, sex, ethnicity, creatinine level, and urologic 
abnormality), creatinine (OR, 3.67; 95% CI, 1.69–8.11) was the only independent risk factor for bacteremia. The 
author explained that hypotension from bacteremia decreases blood flow of the kidney, resulting in increased 
creatinine levels9. The author included only WBC and creatinine as laboratory parameters; hence, the results 
would be different from our results.
An increased ALT level was suggested as an independent risk factor for bacteremic UTI. Kim et al.16 retrospec-
tively reviewed 883 pediatric patients with acute pyelonephritis and reported that a high ALT level (>50 IU/L) 
increased the risk of concomitant bacteremia (OR, 2.22; 95% CI, 1.08–4.56; P = 0.03). The authors suggested a 
possible mechanism, such as active participation of hepatocytes in the immune response during sepsis. However, 
we found no differences in the ALT level between patients with bacteremic and non-bacteremic UTI (P = 0.756). 
This may be because of differences in the patient cohort and definition of the disease. The former study enrolled 
children with acute pyelonephritis, which was defined as satisfying both a positive urine culture and renal scin-
tigraphy with DMSA. DMSA positivity indicates more severe inflammation caused by UTI; thus, children with 
a higher probability of more severe disease were enrolled in the study. Furthermore, the former study enrolled 
older patients than those in our study (36% were infants <3 months were; 43% were 4–12 months; 21% were >12 
months).
Among the bacterial pathogens, E. coli is the most common pathogen in bacteremic UTI in both children 
and adults4,10,15. The relationship between the virulence genotype of E. coli strains and risk of bacteremic UTI was 
studied previously. Bonacorsi et al.32 compared E. coli isolates causing bacteremic and non-bacteremic UTI in 83 
male infants younger than 90 days. The authors suggested that the absence of both hemolysin and antigen K1 are 
negative predictive factors for bacteremia.
An indwelling urinary catheter has been frequently identified as a risk factor for urosepsis in adult26,33. In 
a pediatric study, however, Roman et al.4 reported no significant difference between infants with bacteremic 
UTI and non-bacteremic UTI in terms of comorbidities, including immunodeficiency, neuromuscular disorders, 
and the presence of the indwelling urinary or central venous catheter. In our study, no enrolled patients had an 
indwelling catheter.
VUR is known to be predisposing for ascending kidney infection, renal scarring, and urosepsis in children9,34. 
A prevalence of 0.4–1.8% has been estimated for children without other concomitant conditions35. Swerkersson 
et al. reported VUR in 80 of 303 children (26%) younger than 2 years with a first-time, culture-verified UTI36. In 
the present study, VUR was detected nearly two-fold as frequently in patients with bacteremic UTI than in those 
with non-bacteremic UTI (59.3% vs. 30.6%; P = 0.003). Multivariate analysis revealed that if the infant had VUR, 
then the risk of bacteremic UTI was increased by approximately four-fold. Megged9 reported that children with 
bacteremic UTI (n = 26; mean age, 30 ± 49 months) were more inclined to have urogenital abnormalities than 
those with non-bacteremic UTI (n = 438; mean age, 53 ± 48 months) (13% vs. 5%; P = 0.04), but found no asso-
ciation in multivariate analysis.
Although the guidelines of the American Academy of Pediatrics do not recommend routine VCUG in every 
febrile infant with a first UTI, we suggest that imaging studies should be performed to evaluate the presence of 
VUR infants with bacteremic UTI.
A UTI may lead to acute renal parenchymal damage and permanent renal scarring37. Substantial scarring 
may lead to decreased kidney function and has been associated with subsequent hypertension, proteinuria, and 
end-stage renal disease38–42. However, the potential impact of concomitant bacteremia in UTI on both renal 
scarring and the development of renal insufficiency remains uncertain. In our study, cortical defects on DMSA 
scan were more frequently found in bacteremic UTI patients (60.9%) than non-bacteremic UTI patients (33.0%) 
during the acute stage, whereas most cases for whom follow-up DMSA was performed six months after UTI 
showed resolution or improved status of cortical defects (91.3%). Moreover, we found no difference in cases 
showing impaired renal function or proteinuria at follow-up. Previous studies regarding the long-term outcomes 
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for children with UTI showed no significant decline in renal function after childhood UTI39,43. However, other 
long-term studies have shown that the onset of complications after UTI (e.g. hypertension, proteinuria, and 
chronic renal disease) may actually present after a few decades38,40,42. Additionally, we could not investigate the 
baseline eGFR and the follow-up data in our study were obtained in too few patients to generalize the results. 
Therefore, further large-scale studies are required to assess the long-term clinical outcome of bacteremic UTI 
patients, estimate their prognoses, and determine appropriate management.
The present study had several limitations. First, this was a retrospective study performed at a single, tertiary 
hospital. Therefore, the severity of disease may be skewed, and further multicenter studies are required to validate 
the study results. Second, data regarding previous antimicrobial use and hospitalizations were excluded because 
of the limited availability of this information. Third, the predictive capacity with other laboratory markers, such 
as PCT, could not be compared. Fourth, we could not assess the development of hypertension or the recurrence 
of UTI among enrolled patients.
The present study demonstrated the incidence and various laboratory risk factors for bacteremic UTI in 
infants aged <6 months at initial presentation. Further prospective studies are needed to confirm the diagnostic 
accuracy of these laboratory parameters under various patient cohorts and hospital settings to establish reliable 
cutoff values.
conclusions
The present study found that age ≤90 days, higher CRP and DNI levels, and the presence of VUR were signif-
icantly associated with bacteremia in infants with febrile UTI. These findings could be helpful to physicians in 
decision-making for the proper management of febrile infants with pyuria. Imaging studies such as VCUG are 
also recommended in infants with bacteremic UTI for the evaluation of VUR.
Data availability
The datasets used and/or analysed during the current study are available from the corresponding author on 
reasonable request.
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